However, the pathogenic role the IgM+CD21low B cell subset has not been definitively characterized after the initial reports that indicated its potential involvement in RA and in hepatitis C virus infection-related autoimmunity. This evidence concerns the gene CD40LG and rheumatoid arthritis.